On April 04, 2017, Depomed announced that, in accordance with its stated plans and the terms of the secured debt facility with Deerfield and Pharmakon Advisors, L.P., the former prepaid $100 million of principal amount of its $475 million secured indebtedness. In addition, Depomed paid a prepayment fee of $4 million. Under the terms of the seven-year loan agreement, which matures in 2022, Depomed intends to refinance the remainder of the $375 million secured indebtedness in 2017. The free research report on DEPO is available at: